192 related articles for article (PubMed ID: 38804196)
1. Insight into the potential of bone turnover biomarkers: integration in the management of osteoporosis and chronic kidney disease-associated osteoporosis.
Brouwers P; Bouquegneau A; Cavalier E
Curr Opin Endocrinol Diabetes Obes; 2024 Aug; 31(4):149-156. PubMed ID: 38804196
[TBL] [Abstract][Full Text] [Related]
2. Clinical utility of bone turnover markers in patients with chronic kidney disease.
Smout D; Jørgensen HS; Cavalier E; Evenepoel P
Curr Opin Nephrol Hypertens; 2022 Jul; 31(4):332-338. PubMed ID: 35703216
[TBL] [Abstract][Full Text] [Related]
3. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
Hsu CY; Chen LR; Chen KH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
[TBL] [Abstract][Full Text] [Related]
5. Management of osteoporosis in patients with chronic kidney disease.
Abdalbary M; Sobh M; Elnagar S; Elhadedy MA; Elshabrawy N; Abdelsalam M; Asadipooya K; Sabry A; Halawa A; El-Husseini A
Osteoporos Int; 2022 Nov; 33(11):2259-2274. PubMed ID: 35748896
[TBL] [Abstract][Full Text] [Related]
6. Osteoporosis and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Back to Basics.
Pazianas M; Miller PD
Am J Kidney Dis; 2021 Oct; 78(4):582-589. PubMed ID: 33774081
[TBL] [Abstract][Full Text] [Related]
7. Bone turnover markers predict type of bone histomorphometry and bone mineral density in Asian chronic haemodialysis patients.
Laowalert S; Khotavivattana T; Wattanachanya L; Luangjarmekorn P; Udomkarnjananun S; Katavetin P; Eiam-Ong S; Praditpornsilpa K; Susantitaphong P
Nephrology (Carlton); 2020 Feb; 25(2):163-171. PubMed ID: 30980579
[TBL] [Abstract][Full Text] [Related]
8. Bisphophonates in CKD patients with low bone mineral density.
Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
[TBL] [Abstract][Full Text] [Related]
9. Bone Disorders in Chronic Kidney Disease: An Update in Diagnosis and Management.
Babayev R; Nickolas TL
Semin Dial; 2015; 28(6):645-53. PubMed ID: 26332760
[TBL] [Abstract][Full Text] [Related]
10. The use of bone turnover markers in chronic kidney disease-mineral and bone disorders.
Chiang C
Nephrology (Carlton); 2017 Mar; 22 Suppl 2():11-13. PubMed ID: 28429547
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review.
Ginsberg C; Ix JH
Am J Kidney Dis; 2022 Mar; 79(3):427-436. PubMed ID: 34419519
[TBL] [Abstract][Full Text] [Related]
12. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
[TBL] [Abstract][Full Text] [Related]
13. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
[TBL] [Abstract][Full Text] [Related]
14. Bone disease in pediatric chronic kidney disease.
Wesseling-Perry K
Pediatr Nephrol; 2013 Apr; 28(4):569-76. PubMed ID: 23064662
[TBL] [Abstract][Full Text] [Related]
15. Use of biochemical markers of bone turnover in the management of postmenopausal osteoporosis.
Camacho PM; Lopez NA
Clin Chem Lab Med; 2008; 46(10):1345-57. PubMed ID: 18844486
[TBL] [Abstract][Full Text] [Related]
16. Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment.
Haarhaus M; Evenepoel P; ;
Kidney Int; 2021 Sep; 100(3):546-558. PubMed ID: 34102219
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations.
Bover J; Ureña-Torres P; Torregrosa JV; Rodríguez-García M; Castro-Alonso C; Górriz JL; Laiz Alonso AM; Cigarrán S; Benito S; López-Báez V; Lloret Cora MJ; daSilva I; Cannata-Andía J
Nefrologia (Engl Ed); 2018; 38(5):476-490. PubMed ID: 29703451
[TBL] [Abstract][Full Text] [Related]
18. Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder.
Sugatani T
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142896
[TBL] [Abstract][Full Text] [Related]
19. A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease.
Hampson G; Elder GJ; Cohen-Solal M; Abrahamsen B
Endocrine; 2021 Sep; 73(3):509-529. PubMed ID: 33974225
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
